Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Melanie Luppa is active.

Publication


Featured researches published by Melanie Luppa.


Age and Ageing | 2010

Prediction of institutionalization in the elderly. A systematic review

Melanie Luppa; Tobias Luck; Siegfried Weyerer; Hans-Helmut König; Elmar Brähler; Steffi G. Riedel-Heller

OBJECTIVE in the past decades, many studies have examined predictors of nursing home placement (NHP) in the elderly. This study provides a systematic review of predictors of NHP in the general population of developed countries. DESIGN relevant articles were identified by searching the databases MEDLINE, Web of Science, Cochrane Library and PSYNDEXplus. Studies based on population-based samples with prospective study design and identification of predictors by multivariate analyses were included. Quality of studies and evidence of predictors were determined. RESULTS thirty-six studies were identified; one-third of the studies were of high quality. Predictors with strong evidence were increased age, low self-rated health status, functional and cognitive impairment, dementia, prior NHP and a high number of prescriptions. Predictors with inconsistent results were male gender, low education status, low income, stroke, hypertension, incontinence, depression and prior hospital use. CONCLUSIONS findings suggested that predictors of NHP are mainly based on underlying cognitive and/or functional impairment, and associated lack of support and assistance in daily living. However, the methodical quality of studies needs improvement. More theoretical embedding of risk models of NHP would help to establish more clarity in complex relationships in using nursing homes.


Journal of Affective Disorders | 2012

Age- and gender-specific prevalence of depression in latest-life – Systematic review and meta-analysis

Melanie Luppa; Claudia Sikorski; Tobias Luck; Lena Ehreke; Alexander Konnopka; Birgitt Wiese; Siegfried Weyerer; Hans-Helmut König; Sg Riedel-Heller

OBJECTIVE The objective of the study is to systematically analyze the prevalence of depression in latest life (75+), particularly focusing on age- and gender-specific rates across the latest-life age groups. DESIGN Relevant articles were identified by systematically searching the databases MEDLINE, Web of Science, Cochrane Library and Psycinfo and relevant literature from 1999 onwards was reviewed. Studies based on the community-based elderly population aged 75 years and older were included. Quality of studies was assessed. Meta-analysis was performed using random effects model. RESULTS 24 studies reporting age- and gender-specific prevalence of depression were found. 13 studies had a high to moderate methodical quality. The prevalence of major depression ranged from 4.6% to 9.3%, and that of depressive disorders from 4.5% to 37.4%. Pooled prevalence was 7.2% (95% CI 4.4-10.6%) for major depression and 17.1% (95% CI 9.7-26.1%) for depressive disorders. Potential sources of high heterogeneity of prevalence were study design, sampling strategy, study quality and applied diagnostics of latest life depression. CONCLUSIONS Despite the wide variation in estimates, it is evident that latest life depression is common. To reduce variability of study results, particularly sampling strategies (inclusion of nursing home residents and severe cognitively impaired individuals) for the old age study populations should be addressed more thoroughly in future research.


Medical Care Research and Review | 2011

Review: Health Care Utilization and Costs of Elderly Persons With Multiple Chronic Conditions

Thomas Lehnert; Dirk Heider; Hanna Leicht; Sven Heinrich; Sandro Corrieri; Melanie Luppa; Steffi G. Riedel-Heller; Hans-Helmut König

This systematic literature review identified and summarized 35 studies that investigated the relationship between multiple chronic conditions (MCCs) and health care utilization outcomes (i.e. physician use, hospital use, medication use) and health care cost outcomes (medication costs, out-of-pocket costs, total health care costs) for elderly general populations. Although synthesis of studies was complicated because of ambiguous definitions and measurements of MCCs, and because of the multitude of outcomes investigated, almost all studies observed a positive association of MCCs and use/costs, many of which found that use/costs significantly increased with each additional condition. Several studies indicate a curvilinear, near exponential relationship between MCCs and costs. The rising prevalence, substantial costs, and the fear that current care arrangements may be inappropriate for many patients with MCCs, bring about a multitude of implications for research and policy, of which the most important are presented and discussed.


Dementia and Geriatric Cognitive Disorders | 2008

Prediction of institutionalisation in dementia. A systematic review.

Melanie Luppa; Tobias Luck; Elmar Brähler; Hans-Helmut König; Steffi G. Riedel-Heller

Background/Aims: In the past decades, a substantial number of studies considered factors influencing institutionalisation of persons with dementia. This study reviews recent work on predictors of actual institutionalisation in dementia. Method: Relevant articles were identified by a systematic search of the literature. Studies were considered which included persons aged 65 and over, and whose results were based on prospective design and on multivariate statistical analyses. Results: Forty-two studies were identified. The rate of institutionalisation increased from 20% in the first year after diagnosis to 50% after 5 years. Median time to institutionalisation was estimated between 30 and 40 months. Predictors of institutionalisation were classified according to a provided conceptual framework in the categories sociodemographic and relationship characteristics of persons with dementia and caregivers, primary stressors, secondary stressors and resources. Conclusion: The overview of research activities in this area showed a lack of methodological strength in a large part of identified studies. Nevertheless, a lot of well-examined and less highlighted predictors could be identified.


Dementia and Geriatric Cognitive Disorders | 2010

Incidence of Mild Cognitive Impairment: A Systematic Review

Tobias Luck; Melanie Luppa; Susanne Briel; Steffi G. Riedel-Heller

Background/Aims: Subjects with mild cognitive impairment (MCI) constitute a risk population of developing dementia and thus a population of clinical interest. This study reviews recent work on the incidence of MCI in the elderly. Methods: Incidence papers were identified by a systematic literature search. Studies on the incidence of MCI were considered if they identified ‘cognitively mildly impaired’ subjects by application of the MCI criteria, used the ‘person-years-at-risk’ method, and were based on population- or community-based samples. Results: Nine studies were identified. The incidence of amnestic MCI subtypes ranged between 9.9 and 40.6 per 1,000 person-years, and the incidence of non-amnestic MCI subtypes was 28 and 36.3 per 1,000 person-years. Regarding any MCI, incidence rates of 51 and 76.8 per 1,000 person-years were found. A higher risk of incident MCI mainly resulted for higher age, lower education and hypertension. Discussion: The incidence rates of MCI varied widely, and possible risk factors for incident MCI were analysed only to a limited extent. The findings call for an agreement concerning the criteria used for MCI and the operationalisation of these criteria.


Journal of Affective Disorders | 2008

Prevalence and risk factors for depression in non-demented primary care attenders aged 75 years and older

Siegfried Weyerer; Sandra Eifflaender-Gorfer; Leonore Köhler; Frank Jessen; Wolfgang Maier; Angela Fuchs; Michael Pentzek; Hanna Kaduszkiewicz; Cadja Bachmann; Matthias C. Angermeyer; Melanie Luppa; Birgitt Wiese; Edelgard Mösch; Horst Bickel

BACKGROUND Depression among the elderly is an important public health issue. The aims of this study were to report the prevalence of depression and to determine the impact of socio-demographic variables, functional impairment and medical diagnoses, lifestyle factors, and mild cognitive impairment on depression as part of the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe Study). METHODS Included in the cross-sectional survey were 3327 non-demented subjects aged 75 and over attending general practitioners (GPs) (n=138) in an urban area of Germany. The GDS-15 Geriatric Depression Scale was used to measure depression with a threshold of <6/6+. Associations with social and clinical risk factors were assessed by means of multiple logistic regression models. RESULTS The prevalence of depression was 9.7% (95% confidence interval 8.7-10.7). In a univariate analysis, the following variables were significantly associated with depression: female gender, increasing age, living alone, divorce, lower educational status, functional impairment, comorbid somatic disorder, mild cognitive impairment, smoking, and abstinence from alcohol. After full adjustment for confounding variables, odds ratios for depression were significantly higher only for functional impairment, smoking, and multi-domain mild cognitive impairment. LIMITATIONS Recruitment procedures might have led to an underestimation of current prevalence. The cross-sectional data did not allow us to analyze the temporal relationship between risk factors and depression. CONCLUSIONS The prevalence of depression in the elderly is high and remains high into old age. In designing prevention programs, it is important to call more attention to the impact of functional and cognitive impairment on depression.


Acta Psychiatrica Scandinavica | 2010

Cost‐of‐illness studies of dementia: a systematic review focusing on stage dependency of costs

Wilm Quentin; Sg Riedel-Heller; Melanie Luppa; A. Rudolph; Hans-Helmut König

Quentin W, Riedel‐Heller SG, Luppa M, Rudolph A, König H‐H. Cost‐of‐illness studies of dementia: a systematic review focusing on stage dependency of costs.


Psychotherapy and Psychosomatics | 2012

Economics of Medically Unexplained Symptoms: A Systematic Review of the Literature

Alexander Konnopka; Rainer Schaefert; Sven Heinrich; Claudia Kaufmann; Melanie Luppa; Wolfgang Herzog; Hans-Helmut König

Objective: To review cost-of-illness studies (COI) and economic evaluations (EE) conducted for medically unexplained symptoms and to analyze their methods and results. Methods: We searched the databases PubMed, PsycINFO and National Health Service Economic Evaluations Database of the University of York. Cost data were inflated to 2006 using country-specific gross domestic product inflators and converted to 2006 USD purchasing power parities. Results: We identified 5 COI and 8 EE, of which 6 were cost-minimization analyses and 2 were cost-effectiveness analyses. All studies used patient level data collected between 1980 and 2004 and were predominantly conducted in the USA (n = 10). COI found annual excess health care costs of somatizing patients between 432 and 5,353 USD in 2006 values. Indirect costs were estimated by only one EE and added up to about 18,000 USD per year. In EE, educational interventions for physicians as well as cognitive-behavioral therapy approaches for patients were evaluated. For both types of interventions, effectiveness was either shown within EE or by previous studies. Most EE found (often insignificant) cost reductions resulting from the interventions, but only two studies explicitly combined changes in costs with data on effectiveness to cost-effectiveness ratios (ratio of additional costs to additional effects). Conclusions: Medically unexplained symptoms cause relevant annual excess costs in health care that are comparable to mental health problems like depression or anxiety disorders and which may be reduced by interventions targeting physicians as well as patients. More extensive research on indirect costs and cost-effectiveness is needed.


Acta Psychiatrica Scandinavica | 2011

Net costs of dementia by disease stage.

Hanna Leicht; Sven Heinrich; Dirk Heider; Cadja Bachmann; Horst Bickel; H. van den Bussche; Angela Fuchs; Melanie Luppa; W. Maier; Edelgard Mösch; Michael Pentzek; S. G. Rieder‐Heller; Franziska Tebarth; Jochen Werle; Siegfried Weyerer; Birgitt Wiese; Thomas Zimmermann; Hans-Helmut König

Leicht H, Heinrich S, Heider D, Bachmann C, Bickel H, van den Bussche H, Fuchs A, Luppa M, Maier W, Mösch E, Pentzek M, Rieder‐Heller SG, Tebarth F, Werle J, Weyerer S, Wiese B, Zimmermann T, König H‐H, for the AgeCoDe study group. Net costs of dementia by disease stage.


Acta Psychiatrica Scandinavica | 2010

Risk factors for incident mild cognitive impairment – results from the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe)

Tobias Luck; Sg Riedel-Heller; Melanie Luppa; Birgitt Wiese; Anja Wollny; Michael Wagner; Horst Bickel; Siegfried Weyerer; Michael Pentzek; Franziska Haller; Edelgard Moesch; Jochen Werle; Marion Eisele; W. Maier; H. van den Bussche; Hanna Kaduszkiewicz

Luck T, Riedel‐Heller SG, Luppa M, Wiese B, Wollny A, Wagner M, Bickel H, Weyerer S, Pentzek M, Haller F, Moesch E, Werle J, Eisele M, Maier W, van den Bussche H, Kaduszkiewicz H for the AgeCoDe Study Group. Risk factors for incident mild cognitive impairment – results from the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe).

Collaboration


Dive into the Melanie Luppa's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael Pentzek

University of Düsseldorf

View shared research outputs
Top Co-Authors

Avatar

Angela Fuchs

University of Düsseldorf

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge